AR and prostate cancer: Besides, GATA2 is a pioneer transcription factor for androgen receptor (AR) in prostate cancer, and increased GATA2 and its AR-independent transactivation of IGF2 could mediate taxane resistance through the activation of IGF1/insulin receptor signaling [34].